FDA: Genentech Psoriasis Drug Raptiva to Get Warning on Fatal Infections

The Food and Drug Administration announced today that the label of Genentech Inc's psoriasis...

» read full story

October 17th, 2008 - 14:01

Combined Treatment of Rituxan and Chemotherapy Proves Efficient in Leukemia

Genentech Inc. and Biogen Idec Inc. announced that their drug Rituxan combined with chemotherapy...

» read full story

October 08th, 2008 - 14:40

Case of Deadly Brain Infection Prompts Labeling Revisal for Rituxan

The labeling for cancer and rheumatoid arthritis drug Rituxan is being revised after the US Food...

» read full story

September 12th, 2008 - 15:38

Rituxan Treatment Associated With Brain Disorder Death

The Food and Drug Administration says that a woman passed away due to a brain infection with...

» read full story

September 12th, 2008 - 15:20

Rituxan Fails in Lupus Trial; Shares of Genentech and Biogen Drop

Shares of Genentech Inc. and Biogen Idec Inc. sagged on Tuesday after the companies said their...

» read full story

April 30th, 2008 - 15:38

Cancer Drug Rituxan May Help Treat Multiple Sclerosis

The novel cancer and rheumatoid arthritis drug Rituxan has proven to be effective when administered...

» read full story

February 14th, 2008 - 18:07

Cephalon’s Treanda Effective Against NHL

This Saturday Cephalon Inc. declared that its experimental cancer drug Treanda proved to be...

» read full story

December 11th, 2007 - 01:17

FDA Warns about PML Case in Woman Taking Rituxan

A fatal case of progressive multifocal leukoencephalopathy, or PML, in a patient treated with...

» read full story

September 14th, 2008 - 14:45